Acquiring of the patent in China;
Logical distributions approving the R&D work performed;
Declaration of the execution of a clinical method of activity concentrate by INAF at Laval University in Quebec City, in organization with Nestlé Health Science.
TOTUM•070, decrease of LDL-hypercholesterolemia (“awful cholesterol”)
Dispatch of the HEART Phase II clinical review;
Finish of enrollment affirmed in September.
TOTUM•854, decrease of circulatory strain
Speed increase of the improvement program following the introduction of preclinical information at the yearly congress of the European Society of Hypertension and the International Society of Hypertension;
Dispatch of three clinical investigations that could prompt commercialization as long as 3 years in front of the underlying arrangement.
Reinforcing the association
Getting of ISO-9001:2015 confirmation for all the Company’s exercises;
Arrangement of Sébastien BESSY as Chief Operating Marketing and Business Officer.
A drawn out secure monetary circumstance
Income of €25.8 million as of June 30, 2021;
Monetary perceivability until the principal half of 2024, barring likely extra incomes.
Valbiotis (FR0013254851 – ALVAL, PEA/SME qualified) (Paris:ALVAL), a French innovative work organization focused on logical advancement for forestalling and fighting metabolic sicknesses, distributes its monetary report for the main portion of 2021 and gives a report on the Company’s advancement
SUBSCRIBE TO OUR NEWSLETTER
First NameLast NameEmail AddressContact NumberJob TitleCompany NameCountry Name Select AfghanistanAlbaniaAlgeriaAndorraAngolaAntigua and BarbudaArgentinaArmeniaAustraliaAustriaAustrian EmpireAzerbaijanBaden*Bahamas, TheBahrainBangladeshBarbadosBavaria*BelarusBelgiumBelizeBenin (Dahomey)BoliviaBosnia and HerzegovinaBotswanaBrazilBruneiBrunswick and LüneburgBulgariaBurkina Faso (Upper Volta)BurmaBurundiCabo VerdeCambodiaCameroonCanadaCayman Islands, TheCentral African RepublicCentral American Federation*ChadChileChinaColombiaComorosCongo Free State, TheCosta RicaCote d’Ivoire (Ivory Coast)CroatiaCubaCyprusCzechiaCzechoslovakiaDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicDuchy of Parma, The*East Germany (German Democratic Republic)*EcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFederal Government of Germany (1848-49)*FijiFinlandFranceGabonGambia, TheGeorgiaGermanyGhanaGrand Duchy of Tuscany, The*GreeceGrenadaGuatemalaGuineaGuinea-BissauGuyanaHaitiHanover*Hanseatic Republics*Hawaii*Hesse*Holy SeeHondurasHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJamaicaJapanJordanKazakhstanKenyaKingdom of Serbia/Yugoslavia*KiribatiKoreaKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLew Chew (Loochoo)*LiberiaLibyaLiechtensteinLithuaniaLuxembourgMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMauritaniaMauritiusMecklenburg-Schwerin*Mecklenburg-Strelitz*MexicoMicronesiaMoldovaMonacoMongoliaMontenegroMoroccoMozambiqueNamibiaNassau*NauruNepalNetherlands, TheNew ZealandNicaraguaNigerNigeriaNorth German Confederation*North German Union*North MacedoniaNorwayOldenburg*OmanOrange Free State*PakistanPalauPanamaPapal States*Papua New GuineaParaguayPeruPhilippinesPiedmont-Sardinia*PolandPortugalQatarRepublic of Genoa*Republic of Korea (South Korea)Republic of the CongoRomaniaRussiaRwandaSaint Kitts and NevisSaint LuciaSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSchaumburg-Lippe*SenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon Islands, TheSomaliaSouth AfricaSouth SudanSpainSri LankaSudanSurinameSwedenSwitzerlandSyriaTajikistanTanzaniaTexas*ThailandTimor-LesteTogoTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTuvaluTwo Sicilies*UgandaUkraineUnion of Soviet Socialist Republics*United Arab Emirates, TheUnited Kingdom, TheUruguayUzbekistanVanuatuVenezuelaVietnamWürttemberg*YemenZambiaZimbabwe
I would like to receive information from suppliers sponsoring this content and willing to share the information above with business book 25.SEND